| Uliledlimab | TJD-5; TJ-004309; TJ-4309 | Phase 3 Clinical | I-Mab Biopharma Co Ltd | Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | Details |
| Quemliclustat | AB-680 | Phase 3 Clinical | Arcus Biosciences Inc | Adenocarcinoma; Bile Duct Neoplasms; Biliary Tract Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colorectal Neoplasms; Hormone-Resistant Prostate Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant | Details |
| Oleclumab | MEDI-9447 | Phase 3 Clinical | Medimmune Llc | Adenocarcinoma; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Colorectal Neoplasms; Fallopian Tube Neoplasms; Hemangiosarcoma; Liposarcoma; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms | Details |
| Dalutrafusp alfa | GS-1423; AGEN-1423 | Phase 2 Clinical | Agenus Inc | Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours | Details |
| BMS-986179 | BMS-986179 | Phase 2 Clinical | Bristol-Myers Squibb Company | | Details |
| Mupadolimab | CPX-006; COR-004 (Corvus Pharmaceuticals); CPI-006 | Phase 2 Clinical | Corvus Pharmaceuticals Inc | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Endometrial Neoplasms; Head and Neck Neoplasms; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Papillomavirus Infections; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | Details |
| XW-LTH-03 | XW-LTH-03 | Phase 2 Clinical | Shanghai SinoBay Biotechnology Co Ltd | | Details |
| CD73/AXL.HypoSti.CAR-T cells therapy (Pla General Hospital) | | Phase 2 Clinical | Pla General Hospital | | Details |
| Dresbuxelimab | AK-119 | Phase 2 Clinical | | Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis; Solid tumours | Details |
| GI-108 | GI-108 | Phase 2 Clinical | GI Innovation Inc | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Neoplasms; Pancreatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck | Details |
| S-095024 | S-095024; S095024 | Phase 2 Clinical | Institut De Recherches Internationales Servier, Regeneron Pharmaceuticals Inc, Servier Bio-Innovation LLC | Carcinoma, Non-Small-Cell Lung | Details |
| HB-0052 | HB0052; HB-0052 | Phase 2 Clinical | Shanghai Huaota Biopharmaceutical Co Ltd, Zhejiang Huahai Pharmaceutical Co Ltd | Pancreatic Neoplasms; Solid tumours | Details |
| HB-0045 | HB-0045; HB0045 | Phase 2 Clinical | HuaBo Biopharm Co Ltd, Shanghai Huaota Biopharmaceutical Co Ltd | | Details |
| JAB-BX102 | JAB-BX102 | Phase 2 Clinical | Jacobio Pharmaceuticals Co Ltd | | Details |
| PT-199 | PT-199 | Phase 2 Clinical | Phanes Therapeutics Inc | Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Solid tumours | Details |
| LY-3475070 | LY-3475070 | Phase 1 Clinical | Eli Lilly And Company | | Details |
| Anti-CD73 monoclonal antibody (Bristol-Myers Squibb) | | Phase 1 Clinical | Bristol-Myers Squibb Company | | Details |
| AP-601 | AP-601 | Phase 1 Clinical | AP Biosciences Inc | | Details |
| 68Ga-dPNE | 68Ga-dPNE | Phase 1 Clinical | First Affiliated Hospital Of Fujian Medical University | | Details |
| AK-137 | AK137; AK-137 | Phase 1 Clinical | | | Details |
| 68GA-DOTA-dPNE | 68GA-DOTA-dPNE | Phase 1 Clinical | Peking Union Medical College Hospital | | Details |
| LNF-2008 | LNF-2008; LNF2008 | Phase 1 Clinical | Shandong New Time Pharmaceutical Co Ltd | | Details |
| HB-0046 | HB0046; HB-0046 | Phase 1 Clinical | HuaBo Biopharm Co Ltd, Shanghai Huaota Biopharmaceutical Co Ltd | | Details |
| SYS-6011 | SYS6011; SYS-6011 | Phase 1 Clinical | Jushi Biopharmaceutical Co Ltd | | Details |
| BPI-472372 | BPI-472372 | Phase 1 Clinical | Betta Pharmaceuticals Co Ltd | | Details |
| BB-1709 | BB-1709 | Phase 1 Clinical | Bliss Biopharmaceutical (Hangzhou) Co Ltd | | Details |
| PM-1015 | PM1015; PM-1015 | Phase 1 Clinical | | | Details |
| AK-131 | AK-131 | Phase 1 Clinical | | | Details |
| IBI-325 | IBI-325 | Phase 1 Clinical | | | Details |
| BR-101 | BR101; BR-101 | Phase 1 Clinical | Zhejiang BioRay Biopharmaceuticals Co Ltd | | Details |
| CB-708 | ATG-037; ATN-037; CB-708; CB708 | Phase 1 Clinical | Calithera Biosciences Inc | Carcinoma, Non-Small-Cell Lung; Melanoma; Neoplasms; Solid tumours | Details |
| HLX-23 | HLX-23 | Phase 1 Clinical | | | Details |
| ORIC533 | ORIC-533 | Phase 1 Clinical | Oric Pharmaceuticals Inc | Multiple Myeloma; Neoplasm Metastasis | Details |
| IPH-5301 | IPH-5301 | Phase 1 Clinical | Innate Pharma | Breast Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Lung Neoplasms; Metastatic breast cancer; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Solid tumours; Stomach Neoplasms | Details |
| HBM-1007 | HBM1007; R 1007; HBM 1007; HBM-1007 | Phase 1 Clinical | Harbour Biomed | | Details |
| ABSK-051 | ABSK051 | Phase 1 Clinical | ABbisko Therapeutics Co Ltd | | Details |
